Oriental Medicines Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 09-12-2024
- Paid Up Capital ₹ 1.16 M
as on 09-12-2024
- Company Age 42 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 9.28 Cr
as on 09-12-2024
- Revenue -13.41%
(FY 2020)
- Profit -173.37%
(FY 2020)
- Ebitda -600.57%
(FY 2020)
- Net Worth -6.58%
(FY 2020)
- Total Assets 5.88%
(FY 2020)
About Oriental Medicines
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.16 M.
The company currently has active open charges totaling ₹9.28 Cr.
Remesh Kesavan, Girija Ramesh, Sathy Kesavan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231KL1982PTC003618
- Company No.
003618
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 1982
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Alappuzha, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Oriental Medicines Pvt Ltd offer?
Oriental Medicines Pvt Ltd offers a wide range of products and services, including Ayurvedic Immunity Booster, Chyawanprash, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Health Tonic, Herbal Oil, Massage Oil, Ayurvedic Digestive Medicine, Digestive Herbal Capsule & Tablet, Ayurvedic Joint Pain Relief Medicine, Ayurvedic Joint Pain Relief Capsule Tablet.
Who are the key members and board of directors at Oriental Medicines?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Remesh Kesavan  | Managing Director | 24-Sep-1982 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girija Ramesh | Director | 08-Feb-1996 | Current |
| Sathy Kesavan | Director | 23-Sep-1985 | Current |
| Kesavan Dinesh | Director | 25-Jan-1989 | Current |
| Neeta Dinesh | Director | 08-Feb-1996 | Current |
Financial Performance and Corporate Structure Insights of Oriental Medicines.
Oriental Medicines Pvt Ltd, for the financial year ended 2020, experienced significant reduction in revenue, with a 13.41% decrease. The company also saw a substantial fall in profitability, with a 173.37% decrease in profit. The company's net worth dipped by a decrease of 6.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oriental Medicines?
In 2019, Oriental Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Oriental Extractions Private LimitedActive 27 years 6 monthsRemesh Kesavan and Girija Ramesh are mutual person
- Pioneer Electronics System Private LimitedActive 31 years 3 months
Remesh Kesavan and Girija Ramesh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Federal Bank Limited Creation Date: 16 May 2008 | ₹5.22 Cr | Open |
State Bank Of Travancore Creation Date: 03 May 2006 | ₹1.75 Cr | Open |
State Bank Of Travancore Creation Date: 28 Sep 2005 | ₹2.20 Cr | Open |
How Many Employees Work at Oriental Medicines?
Oriental Medicines has a workforce of 8 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oriental Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oriental Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
